Francisco, Lyka D.

HRN: 22-45-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2023
CEFUROXIME 1.5GM (VIAL)
05/21/2023
05/28/2023
IVT
1.5g
Q8
Acute Bacterial Infection
Waiting Final Action 
05/21/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/21/2023
05/28/2023
IVT
600mg
Q8
Vaginal Infection
Waiting Final Action 
05/24/2023
CEFTRIAXONE 1G (VIAL)
05/24/2023
05/30/2023
IV
4g
Q24
Sepsis
Waiting Final Action 
05/26/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/26/2023
06/02/2023
IV DRIP
3grams
Q8
Sepsis
Waiting Final Action 
05/26/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/26/2023
06/02/2023
IVTT
600mg As LD Then 300mg As MD
Q24
Candidiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: